Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
A phase 4 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 180 participants.
Also called NCT06578234
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; single masking; primary purpose diagnostic
- Phase
- Phase 4
- Enrolled
- 180 participants
- Sponsor
- Registry
-
NCT06578234
-
- Started
- (actual)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Sweden
- Registry status
- Recruiting
Technical summary
Registry record NCT06578234. Randomized; single masking; primary purpose diagnostic. Start 2024-10-23 (actual); primary completion 2026-12-31 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Hyperemic mYocardial Perfusion by adEnosine at diffeRent Doses
- Acronym
- HYPER
- Condition
- Chronic Coronary Syndrome
- Condition
- Coronary Artery Disease
- Condition
- Ischemic Heart Disease
- Intervention (Drug)
- Adenosine
- Lead sponsor
- Region Skane
Record details
- Record id
cardio:ct-nct06578234- Content hash
80ecf9cac08543b24ade4cf000d80d1a854fc9b6bacd5022b9666c65e21a7593